Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5723-5730

  Brand, Karsten ^a   Baker, Andrew H ^b   Perez Cantó, Alejandra ^c   Possling, Alexandra ^a   Sacharjat, Michael ^a   Geheeb, Martina ^a   Arnold, Wolfgang ^d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Biomedical Research Campus Berlin Buch ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE INHIBITOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INFILTRATION; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; LIVER METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL DIVISION; COLORECTAL NEOPLASMS; FEMALE; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034667462     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Current treatment approaches in colorectal cancer
2. Cancer of the lower gastrointestinal tract: Colon cancer
3. Matrix metalloproteinases in cancer: Prognostic markers and targets for therapy
4. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
5. Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic
6. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat
7. Complex role of matrix metalloproteinases in angiogenesis
8. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases
9. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9
10. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia
11. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression
12. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
13. Gelatinase A activity directly modulates melanoma cell adhesion and spreading
14. Changing views of the role of matrix metalloproteinases in metastasis
15. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2
16. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
17. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion
18. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
19. Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells
20. Widespread long-term gene transfer to mouse skeletal muscles and heart
21. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors
22. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection
23. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
24. Experimental nude mouse model of human colorectal cancer liver metastases
25. Metastasis of human colon tumor cells in vivo: Correlation with the overexpression of plasminogen activators and 72 kDa gelatinase
26. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver
27. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
28. Regional 'pro-drug' gene therapy: Intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma
29. Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model
30. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
31. Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice
32. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
33. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice
34. British biotech responds to allegations